However, similarly to other hormones such as FSH, LH, estradiol and prolactin which are also raised markedly in EC patients, these may be markers of the major risk factors, obesity and polycystic ovarian syndrome rather than EC itself, thus showing poorer specificity than required of a screening biomarker. The gene discussed is PRL; the disease is obesity disorder.